Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC |
Soleus Capital Master Fund, L.P. | 6,603,996 9.400% |
4,048,000![]() (+158.37%) |
Filing History |
2024-06-07 08:30 am Purchase |
2024-06-06 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 3,341,120 5.200% |
3,341,120![]() (New Position) |
Filing History |
2024-02-09 10:32 am Purchase |
2023-12-31 | 13G | Celcuity Inc. CELC |
Soleus Capital Master Fund, L.P. | 2,623,890 9.900% |
338,336![]() (+14.80%) |
Filing History |
2024-02-08 10:08 am Purchase |
2024-02-05 | 13G | CalciMedica, Inc. CALC |
Soleus Capital Master Fund, L.P. | 1,105,016 9.990% |
321,112![]() (+40.96%) |
Filing History |
2024-02-05 10:24 am Purchase |
2024-01-26 | 13G | C4 Therapeutics, Inc. CCCC |
Soleus Capital Master Fund, L.P. | 2,555,996 5.200% |
720,000![]() (+39.22%) |
Filing History |
2024-02-02 09:59 am Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-50,000![]() (Position Closed) |
Filing History |
2024-02-02 09:56 am Purchase |
2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 944,258 5.400% |
21,956![]() (+2.38%) |
Filing History |
2024-02-02 09:54 am Purchase |
2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 8,963,000 6.800% |
1,599,937![]() (+21.73%) |
Filing History |
2024-02-02 09:53 am Sale |
2023-12-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 771,700 5.400% |
-3,611![]() (-0.47%) |
Filing History |
2024-02-02 09:50 am Purchase |
2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Capital Master Fund, L.P. | 987,096 8.800% |
987,096![]() (New Position) |
Filing History |
2024-02-02 09:49 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 1,425,634 6.800% |
128,265![]() (+9.89%) |
Filing History |
2024-02-02 09:44 am Sale |
2023-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 643,206 5.100% |
-101,798![]() (-13.66%) |
Filing History |
2024-02-02 09:42 am Sale |
2023-12-31 | 13G | VYNE Therapeutics Inc. VYNE |
Soleus Capital Master Fund, L.P. | 703,868 5.000% |
-187,000![]() (-20.99%) |
Filing History |
2024-02-02 09:41 am Purchase |
2023-12-31 | 13G | EDAP TMS S.A. EDAP |
Soleus Capital Master Fund, L.P. | 7,226,341 19.600% |
2,091,911![]() (+40.74%) |
Filing History |
2024-02-02 09:37 am Sale |
2023-12-31 | 13G | Delcath Systems, Inc. DCTH |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-806,420![]() (Position Closed) |
Filing History |
2024-02-02 09:34 am Sale |
2023-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Soleus Capital Master Fund, L.P. | 1,835,996 3.700% |
-626,024![]() (-25.43%) |
Filing History |
2024-02-02 09:29 am Sale |
2023-12-31 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 2,595,815 6.000% |
-945,483![]() (-26.70%) |
Filing History |
2024-01-26 4:15 pm Purchase |
2024-01-23 | 13G | CalciMedica, Inc. CALC |
Soleus Capital Master Fund, L.P. | 783,904 7.400% |
783,904![]() (New Position) |
Filing History |
2023-11-28 4:52 pm Purchase |
2023-11-27 | 13D | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 5,188,876 10.500% |
5,188,876![]() (New Position) |
Filing History |
2023-11-02 4:15 pm Purchase |
2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE |
Soleus Capital Master Fund, L.P. | 890,868 6.400% |
890,868![]() (New Position) |
Filing History |